The Precision Peptide Company Inc. PNGAF
0.18 USD -0.03 (-13.76%)
At closeNov 6, 2026, 4:00 PM EST
0.1811 Day range 0.2199
0.0077 52-week range 0.4099
- YTD
- -12.26%
- 1 year
- -34.26%
News
newsfilecorp.com The Precision Peptide Company Moves Early on New Federal Peptide Policy, Adding All Six Covered Peptides to Its Prescription Platform Highlights All six peptides covered by the new HHS policy being added: BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500 are being added to the Company's prescription platform, with availability to…
newsfilecorp.com The Precision Peptide Company's Needle-Free First Strategy Already in Place as HHS Draft Policy Recognizes Non-Injectable Routes for Leading Peptides Highlights Federal path for BPC-157: HHS has published a draft Enforcement Discretion Policy concerning a potential interim 503A compounding path for six peptides: BPC-157, Epitalon, KPV, MOTS-c,…
benzinga.com Mixed Martial Arts Group Enters Strategic Marketing Partnership With The Precision Peptide Company, Including 50-50 Revenue Sharing Under the agreement, MMA.INC will market Precision's products across its global combat sports ecosystem and will receive 50% of net revenue derived from MMA-Sourced Sales during the first twelve…